A Novel combination carrying A Hope for treatment of HIV
Versandkostenfrei!
Versandfertig in 6-10 Tagen
20,99 €
inkl. MwSt.
PAYBACK Punkte
10 °P sammeln!
Although HIV-1 has been the most studied infectious agent in the last 30 years and Its widely believed that induction of neutralizing antibodies were sufficient for the protection against HIV . A novel mode of action of HIV infection assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protection against destruction by the cytotoxic CD8+ T-cells. This postulation differs from the ordinary rationales that depend on the role of neutralizing antibodies in controlling the HIV infection. In This book we introduce V20E as a new therap...
Although HIV-1 has been the most studied infectious agent in the last 30 years and Its widely believed that induction of neutralizing antibodies were sufficient for the protection against HIV . A novel mode of action of HIV infection assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protection against destruction by the cytotoxic CD8+ T-cells. This postulation differs from the ordinary rationales that depend on the role of neutralizing antibodies in controlling the HIV infection. In This book we introduce V20E as a new therapeutic immune peptides modality with a highly promising cure for HIV-1 disease and human immunodeficiency syndrome.
Andere Kunden interessierten sich für
